newsfilter
← Latest News
Business Wire·

Taro Provides Results for September 30, 2022

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today provided unaudited financial results for the quarter and six months ended September 30, 2022. Quarter ended September 30, 2022*